Poseida Therapeutics (PSTX) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free PSTX Stock Alerts $2.13 +0.08 (+3.90%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Poseida Therapeutics Short Interest DataCurrent Short Volume4,050,000 sharesPrevious Short Volume4,120,000 sharesChange Vs. Previous Month-1.70%Dollar Volume Sold Short$9.84 millionShort Interest Ratio / Days to Cover5.4Last Record DateApril 15, 2024Outstanding Shares96,490,000 sharesFloat Size61,790,000 sharesShort Percent of Float6.55%Today's Trading Volume461,299 sharesAverage Trading Volume511,623 sharesToday's Volume Vs. Average90% Short Selling Poseida Therapeutics ? Sign up to receive the latest short interest report for Poseida Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPSTX Short Interest Over TimePSTX Days to Cover Over TimePSTX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Poseida Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,050,000 shares $9.84 million -1.7%6.6%5.4 $2.43 3/31/20244,120,000 shares $13.14 million +7.3%6.7%5.7 $3.19 3/15/20243,840,000 shares $12.36 million +11.3%6.2%5.3 $3.22 2/29/20243,450,000 shares $13.66 million -6.0%5.6%3.4 $3.96 2/15/20243,670,000 shares $13.58 million +1.4%6.0%3.9 $3.70 1/31/20243,620,000 shares $12.45 million +22.7%5.9%3.9 $3.44 Get the Latest News and Ratings for PSTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,950,000 shares $9.00 million +1.4%4.8%3.4 $3.05 12/31/20232,910,000 shares $9.78 million -10.5%4.7%3.5 $3.36 12/15/20233,250,000 shares $10.53 million +10.2%5.3%3.8 $3.24 11/30/20232,950,000 shares $7.88 million -17.8%5.0%3.8 $2.67 11/15/20233,590,000 shares $7.93 million +18.5%6.1%7.4 $2.21 10/31/20233,030,000 shares $6.12 million -22.1%5.7%5.7 $2.02 10/15/20233,890,000 shares $9.10 million -0.5%7.3%4.9 $2.34 9/30/20233,910,000 shares $9.31 million +15.0%7.4%4.9 $2.38 9/15/20233,400,000 shares $6.94 million -6.1%6.4%3.6 $2.04 8/31/20233,620,000 shares $7.57 million -4.5%6.8%3.1 $2.09 8/15/20233,790,000 shares $9.63 million -5.5%7.1%3.3 $2.54 7/31/20234,010,000 shares $6.94 million -2.9%6.5%3.6 $1.73 7/15/20234,130,000 shares $7.85 million -6.6%6.7%4.7 $1.90 6/30/20234,420,000 shares $7.78 million +5.0%8.1%4.7 $1.76 6/15/20234,210,000 shares $10.40 million -10.2%7.7%5 $2.47 5/31/20234,690,000 shares $10.65 million +3.3%8.5%7 $2.27 5/15/20234,540,000 shares $13.39 million +3.2%8.3%6.1 $2.95 4/30/20234,400,000 shares $11.62 million +4.0%8.0%5.9 $2.64 4/15/20234,230,000 shares $9.52 million +19.5%7.7%5.8 $2.25 3/31/20233,540,000 shares $10.90 million +2.0%6.4%5.5 $3.08 3/15/20233,470,000 shares $14.44 million +18.4%6.3%5.6 $4.16 2/28/20232,930,000 shares $16.67 million +10.2%5.4%4.9 $5.69 2/15/20232,660,000 shares $18.83 million -14.7%4.8%4.8 $7.08 1/31/20233,120,000 shares $21.72 million -0.3%5.7%5.9 $6.96 1/15/20233,130,000 shares $22.04 million +13.8%5.7%6.6 $7.04 12/30/20222,750,000 shares $14.58 million +10.4%5.0%6.1 $5.30 12/15/20222,490,000 shares $15.49 million +19.1%4.5%5.8 $6.22 11/30/20222,090,000 shares $9.53 million -4.6%3.8%5.2 $4.56 11/15/20222,190,000 shares $10.53 million +10.1%4.0%6.3 $4.81 10/31/20221,990,000 shares $8.16 million +2.1%3.6%5.5 $4.10 10/15/20221,950,000 shares $8.39 million +4.8%3.5%1.3 $4.30 9/30/20221,860,000 shares $6.57 million +20.8%3.4%1.3 $3.53 9/15/20221,540,000 shares $5.61 million +5.5%2.8%1.1 $3.64 8/31/20221,460,000 shares $4.83 million -0.7%3.3%1 $3.31The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him PSTX Short Interest - Frequently Asked Questions What is Poseida Therapeutics' current short interest? Short interest is the volume of Poseida Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,050,000 shares of PSTX short. 6.55% of Poseida Therapeutics' shares are currently sold short. Learn More on Poseida Therapeutics' current short interest. What is a good short interest ratio for Poseida Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTX shares currently have a short interest ratio of 5.0. Learn More on Poseida Therapeutics's short interest ratio. Which institutional investors are shorting Poseida Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Poseida Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Poseida Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.55% of Poseida Therapeutics' floating shares are currently sold short. Is Poseida Therapeutics' short interest increasing or decreasing? Poseida Therapeutics saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 4,050,000 shares, a decrease of 1.7% from the previous total of 4,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Poseida Therapeutics' float size? Poseida Therapeutics currently has issued a total of 96,490,000 shares. Some of Poseida Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Poseida Therapeutics currently has a public float of 61,790,000 shares. How does Poseida Therapeutics' short interest compare to its competitors? 6.55% of Poseida Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Poseida Therapeutics: Compass Therapeutics, Inc. (1.88%), Elevation Oncology, Inc. (13.03%), X4 Pharmaceuticals, Inc. (7.30%), Century Therapeutics, Inc. (6.91%), Opthea Limited (0.21%), Innate Pharma S.A. (0.10%), Acumen Pharmaceuticals, Inc. (2.40%), Adverum Biotechnologies, Inc. (7.54%), Cardiff Oncology, Inc. (8.93%), Sutro Biopharma, Inc. (3.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Poseida Therapeutics stock? Short selling PSTX is an investing strategy that aims to generate trading profit from Poseida Therapeutics as its price is falling. PSTX shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Poseida Therapeutics? A short squeeze for Poseida Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTX, which in turn drives the price of the stock up even further. How often is Poseida Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CMPX Short Interest ELEV Short Interest XFOR Short Interest IPSC Short Interest OPT Short Interest IPHA Short Interest ABOS Short Interest ADVM Short Interest CRDF Short Interest STRO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyWall Street Legend Issues New NVDA WarningChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace